Research programme: microsomal prostaglandin E synthase-1 inhibitors - Glenmark Pharmaceuticals
Latest Information Update: 18 May 2020
At a glance
- Originator Glenmark Pharmaceuticals Ltd
- Class Analgesics
- Mechanism of Action Prostaglandin-E synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in India (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in India (PO)